The major limitation of the thiazolidinediones in the
treatment of type 2 diabetes mellitus is:
A. Frequent hypoglycaemic episodes
B. Hyperinsulinemia
C. Lactic acidosis
D. Low hypoglycaemic efficacy in moderate to
severe cases
treatment of type 2 diabetes mellitus is:
A. Frequent hypoglycaemic episodes
B. Hyperinsulinemia
C. Lactic acidosis
D. Low hypoglycaemic efficacy in moderate to
severe cases